Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QLT0074 PDT for Benign Prostatic Hyperplasia
NCT00077012Phase 2Completed
- Sponsor
- QLT Inc.
- Start
- Mar 2003
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of lemuteporfin in benign prostatic hyperplasia (BPH), sponsored by QLT Inc.. Started Mar 2003; status: completed.
02
Drugs
lemuteporfin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00077012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077012.